AmeriServ Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-4,822
Closed -$1.17M 51
2022
Q1
$1.17M Hold
4,822
0.85% 23
2021
Q4
$1.08M Sell
4,822
-30
-0.6% -$6.33K 0.74% 24
2021
Q3
$1.03M Sell
4,852
-291
-6% -$67K 0.8% 24
2021
Q2
$1.25M Sell
5,143
-580
-10% -$143K 0.98% 24
2021
Q1
$1.42M Sell
5,723
-159
-3% -$37.9K 1.22% 16
2020
Q4
$1.35M Buy
+5,882
New +$1.36M 1.33% 17
2019
Q3
$1.29M Sell
6,717
-55
-0.8% -$10.6K 1.76% 10
2019
Q2
$1.25M Sell
6,772
-112
-2% -$20.1K 1.62% 14
2019
Q1
$1.31M Sell
6,884
-115
-2% -$22K 2.73% 11
2018
Q4
$1.36M Sell
6,999
-875
-11% -$171K 3.45% 8
2018
Q3
$1.63M Buy
7,874
+620
+9% +$122K 2.04% 10
2018
Q2
$1.34M Sell
7,254
-678
-9% -$120K 1.8% 14
2018
Q1
$1.35M Buy
7,932
+684
+9% +$126K 1.53% 14
2017
Q4
$1.27M Buy
+7,248
New +$1.28M 1.23% 15
2016
Q4
Sell
-6,485
Closed -$1.08M 33
2016
Q3
$1.08M Buy
+6,485
New +$1.1M 1.36% 14
2015
Q3
Sell
-600
Closed -$92K 65
2015
Q2
$92K Buy
+600
New +$96.1K 0.11% 93

Other funds holding AMGN

AmeriServ Wealth Advisors's AMGN Position: Q2 2022 in Review

AmeriServ Wealth Advisors sold out of Amgen (AMGN) in Q2 2022, closing a stake of 4,822 shares — an estimated $1.17M sold.

AmeriServ Wealth Advisors first reported a position in AMGN in Q2 2015 and held it in 16 quarters. The position peaked at $1.63M in Q3 2018. 2,352 funds tracked by Wall St. Rank hold AMGN as of Q2 2022.

  • AmeriServ Wealth Advisors reported no remaining Amgen position as of Q2 2022 after selling out during the quarter.
  • AmeriServ Wealth Advisors sold 4,822 Amgen shares in Q2 2022, an estimated $1.17M.
  • AmeriServ Wealth Advisors first reported a position in Amgen in Q2 2015 and held it in 16 quarters.
  • AmeriServ Wealth Advisors's Amgen position peaked at $1.63M in Q3 2018.
  • 2,352 funds tracked by Wall St. Rank held Amgen as of Q2 2022.

Based on AmeriServ Wealth Advisors's 13F filing for Q2 2022, filed 28 Jul 2022.